Puma Biotechnology Shares More Than Triple On Postive Trial Data
July 22, 2014 at 16:51 PM EDT
Shares of Puma Biotechnology more than tripled in after-hours trade Tuesday after the company reported positive results from a late-stage trial of its breast cancer treatment.
